newspaper
expand_less
expand_more
contrast
light_mode
dark_mode
inventory_2
headphones
play_circle
smartphone
settings
reorder
article
folder_zip
dictionary
live_help
contact_support
dvr
manage_accounts
logout
menu
close
search
arrow_back
arrow_forward
chevron_left
chevron_right
share
bookmark
bookmark_border
thumb_up
thumb_down
info
warning
error
check_circle
cancel
add
remove
edit
delete
visibility
visibility_off
filter_list
sort
more_vert
more_horiz
refresh
download
upload
copy
paste
undo
redo
Listen
Newsletters
Home
AI
World
Politics
Health
Crime & justice
Science & technology
Social issues
Sports
Money
Entertainment
Environment/energy
Military
Culture
Weather
Media
Home
Bias Split
Public Figures
Controversies
Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters
Sign Up!
Sign Up Now!
How our sliders work
About
Contact Us
Newsletter Archive
Media
FAQ
Glossary
Privacy Policy
© 2025 Improve the News Foundation. All rights reserved.
Version 6.13.0
© 2025 Improve the News Foundation.
All rights reserved.
Version 6.13.0
Pharmaceuticals
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use recommended approval of lenacapavir, a twice-yearly injectable drug for HIV prevention, on Friday.
EU Regulator Backs Twice-Yearly HIV Prevention Injection
+5
JUL 26
JUL 26
Global Drug Bust Seizes $65M in Counterfeit Medicines
+6
JUN 27
JUN 27
EU Regulators Find Wegovy, Ozempic Link to Rare Vision Loss
+3
JUN 6
JUN 6
Four States Petition FDA to Lift Abortion Pill Restrictions
+5
JUN 12
JUN 12
Trump Orders Significant Drug Price Cuts
+9
MAY 13
MAY 13
Show More